-transparent.png){kind=logo}
Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563). 1994
Department of Internal Medicine III (Hematology and Oncology), University of Ulm, Germany.
Related Publications
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
June 1995,
Bone marrow transplantation,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
August 1994,
Bone marrow transplantation,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
November 1983,
Canadian Medical Association journal,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
June 2000,
Journal of hematotherapy & stem cell research,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
August 2020,
Bone marrow transplantation,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
June 2000,
British journal of haematology,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
September 1983,
The Nursing clinics of North America,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
October 1993,
Clinical pharmacy,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
July 1986,
Nederlands tijdschrift voor geneeskunde,
B Hertenstein, and
M Stefanic, and
M Sandherr, and
D Bunjes, and
T Mertens, and
R Arnold
February 2009,
Zhongguo shi yan xue ye xue za zhi,
